Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.

Aresvik DM, Øverland T, Lima K, Pettersen RD, Abrahamsen TG.

J Clin Immunol. 2019 Jan;39(1):65-74. doi: 10.1007/s10875-018-0579-7. Epub 2018 Dec 19.

PMID:
30569262
2.

Persistent Organic Pollutants and the Association with Maternal and Infant Thyroid Homeostasis: A Multipollutant Assessment.

Berg V, Nøst TH, Pettersen RD, Hansen S, Veyhe AS, Jorde R, Odland JØ, Sandanger TM.

Environ Health Perspect. 2017 Jan;125(1):127-133. doi: 10.1289/EHP152. Epub 2016 May 24.

3.

Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.

Lundman E, Gaup HJ, Bakkeheim E, Olafsdottir EJ, Rootwelt T, Storrøsten OT, Pettersen RD.

J Cyst Fibros. 2016 May;15(3):318-24. doi: 10.1016/j.jcf.2015.12.017. Epub 2016 Jan 12.

4.

Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features.

Gul KA, Øverland T, Osnes L, Baumbusch LO, Pettersen RD, Lima K, Abrahamsen TG.

J Clin Immunol. 2015 May;35(4):408-15. doi: 10.1007/s10875-015-0153-5. Epub 2015 Mar 27.

PMID:
25814142
5.

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.

McHugh D, Cameron CA, Abdenur JE, Abdulrahman M, Adair O, Al Nuaimi SA, Åhlman H, Allen JJ, Antonozzi I, Archer S, Au S, Auray-Blais C, Baker M, Bamforth F, Beckmann K, Pino GB, Berberich SL, Binard R, Boemer F, Bonham J, Breen NN, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Cariappa R, Carlisle C, Caruso U, Cassanello M, Castilla AM, Ramos DE, Chakraborty P, Chandrasekar R, Ramos AC, Cheillan D, Chien YH, Childs TA, Chrastina P, Sica YC, de Juan JA, Colandre ME, Espinoza VC, Corso G, Currier R, Cyr D, Czuczy N, D'Apolito O, Davis T, de Sain-Van der Velden MG, Delgado Pecellin C, Di Gangi IM, Di Stefano CM, Dotsikas Y, Downing M, Downs SM, Dy B, Dymerski M, Rueda I, Elvers B, Eaton R, Eckerd BM, El Mougy F, Eroh S, Espada M, Evans C, Fawbush S, Fijolek KF, Fisher L, Franzson L, Frazier DM, Garcia LR, Bermejo MS, Gavrilov D, Gerace R, Giordano G, Irazabal YG, Greed LC, Grier R, Grycki E, Gu X, Gulamali-Majid F, Hagar AF, Han L, Hannon WH, Haslip C, Hassan FA, He M, Hietala A, Himstedt L, Hoffman GL, Hoffman W, Hoggatt P, Hopkins PV, Hougaard DM, Hughes K, Hunt PR, Hwu WL, Hynes J, Ibarra-González I, Ingham CA, Ivanova M, Jacox WB, John C, Johnson JP, Jónsson JJ, Karg E, Kasper D, Klopper B, Katakouzinos D, Khneisser I, Knoll D, Kobayashi H, Koneski R, Kozich V, Kouapei R, Kohlmueller D, Kremensky I, la Marca G, Lavochkin M, Lee SY, Lehotay DC, Lemes A, Lepage J, Lesko B, Lewis B, Lim C, Linard S, Lindner M, Lloyd-Puryear MA, Lorey F, Loukas YL, Luedtke J, Maffitt N, Magee JF, Manning A, Manos S, Marie S, Hadachi SM, Marquardt G, Martin SJ, Matern D, Mayfield Gibson SK, Mayne P, McCallister TD, McCann M, McClure J, McGill JJ, McKeever CD, McNeilly B, Morrissey MA, Moutsatsou P, Mulcahy EA, Nikoloudis D, Norgaard-Pedersen B, Oglesbee D, Oltarzewski M, Ombrone D, Ojodu J, Papakonstantinou V, Reoyo SP, Park HD, Pasquali M, Pasquini E, Patel P, Pass KA, Peterson C, Pettersen RD, Pitt JJ, Poh S, Pollak A, Porter C, Poston PA, Price RW, Queijo C, Quesada J, Randell E, Ranieri E, Raymond K, Reddic JE, Reuben A, Ricciardi C, Rinaldo P, Rivera JD, Roberts A, Rocha H, Roche G, Greenberg CR, Mellado JM, Juan-Fita MJ, Ruiz C, Ruoppolo M, Rutledge SL, Ryu E, Saban C, Sahai I, García-Blanco MI, Santiago-Borrero P, Schenone A, Schoos R, Schweitzer B, Scott P, Seashore MR, Seeterlin MA, Sesser DE, Sevier DW, Shone SM, Sinclair G, Skrinska VA, Stanley EL, Strovel ET, Jones AL, Sunny S, Takats Z, Tanyalcin T, Teofoli F, Thompson JR, Tomashitis K, Domingos MT, Torres J, Torres R, Tortorelli S, Turi S, Turner K, Tzanakos N, Valiente AG, Vallance H, Vela-Amieva M, Vilarinho L, von Döbeln U, Vincent MF, Vorster BC, Watson MS, Webster D, Weiss S, Wilcken B, Wiley V, Williams SK, Willis SA, Woontner M, Wright K, Yahyaoui R, Yamaguchi S, Yssel M, Zakowicz WM.

Genet Med. 2011 Mar;13(3):230-54. doi: 10.1097/GIM.0b013e31820d5e67.

PMID:
21325949
6.

5-fluorouracil-induced death of Jurkat T-cells--a role for caspases and MCL-1.

Aresvik DM, Pettersen RD, Abrahamsen TG, Wright MS.

Anticancer Res. 2010 Oct;30(10):3879-87.

PMID:
21036698
7.

Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma.

Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Olafsen MR, Gaudernack G.

Cancer Gene Ther. 2005 Aug;12(8):699-707.

PMID:
15846368
8.

Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia.

Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Gaudernack G.

BMC Cancer. 2005 Feb 18;5:20.

9.

CD99 signals caspase-independent T cell death.

Pettersen RD, Bernard G, Olafsen MK, Pourtein M, Lie SO.

J Immunol. 2001 Apr 15;166(8):4931-42.

10.

CD47 and death signaling in the immune system.

Pettersen RD.

Apoptosis. 2000 Oct;5(4):299-306. Review.

PMID:
11227209
11.

CD47 signals T cell death.

Pettersen RD, Hestdal K, Olafsen MK, Lie SO, Lindberg FP.

J Immunol. 1999 Jun 15;162(12):7031-40.

12.
13.

Role of the TCR binding region of the HLA class I alpha 2 domain in regulation of cell adhesion and proliferation.

Pettersen RD, Hestdal K, Lie SO, Gaudernack G.

J Immunol. 1996 Feb 15;156(4):1415-24.

PMID:
8568242
14.

RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules.

Pettersen RD, Hestdal K, Lee N, Geraghty DE, Valø ET, Lie SO, Gaudernack G.

Tissue Antigens. 1995 Mar;45(3):203-12.

PMID:
7539160
15.

[Neonatal screening for metabolic diseases--a task without priority in the Norwegian health policy?].

Pettersen RD, Saugstad OD, Lie SO.

Tidsskr Nor Laegeforen. 1995 Feb 20;115(5):607-8. Norwegian.

PMID:
7900116
16.

[Screening of newborn infants in Norway for severe metabolic disease].

Pettersen RD, Saugstad OD, Heyerdahl S, Motzfeldt K, Lie SO.

Tidsskr Nor Laegeforen. 1995 Feb 20;115(5):584-7. Norwegian.

PMID:
7900109
17.

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients.

Gravem A, Amthor KF, Astrup C, Elgen K, Gjessing LR, Gunby B, Pettersen RD, Kyrdalen L, Vaadal J, Ofsti E, et al.

Acta Psychiatr Scand. 1987 May;75(5):478-86.

PMID:
3300171

Supplemental Content

Loading ...
Support Center